Editorial: Hypertrophic cardiomyopathy

May 1974
British Medical Journal;5/11/1974, Vol. 2 Issue 5914, p290
Academic Journal
No abstract available.


Related Articles

  • The Genetics of Hypertrophic Cardiomyopathy. Maron, Barry J. // Annals of Internal Medicine;Oct86, Vol. 105 Issue 4, p610 

    Editorial. Deals with the genetics of hypertrophic cardiomyopathy. Results of echocardiographic studies on the genetic aspects of the disease; Reasons for the discrepancies among studies of the genetics of hypertrophic cardiomyopathy; Recommendations for genetic counselling.

  • Verapamil in the treatment of hypertrophic cardiomyopathy. Rosing, Douglas R.; Epstein, Stephen E.; Rosing, D R; Epstein, S E // Annals of Internal Medicine;May82, Vol. 96 Issue 5, p670 

    Editorial. Comments on the use of verapamil in the treatment of hypertrophic cardiomyopathy. Beneficial hemodynamic and symptomatic effects of the drug; Overview of several studies conducted concerning the drug; Adverse effects.

  • Pathogenesis of Inherited Forms of Dilated Cardiomyopathy. Graham, Robert M.; Owens, W. Andrew // New England Journal of Medicine;12/02/99, Vol. 341 Issue 23, p1759 

    Editorial. Discusses the discovery of gene defects that cause familial hypertrophic cardiomyopathy and what this means for improved and early diagnosis and the potential for developing therapies for the condition. The most common initial manifestation of idiopathic dilated cardiomyopathy; The...

  • Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy. Blair, Edward; Price, Simon J.; Baty, Catherine J.; Östman-Smith, Ingegerd; Watkins, Hugh // Journal of Medical Genetics;Jun2001, Vol. 38 Issue 6, p385 

    Presents a letter to the editor about familial hypertrophic cardiomyopathy.

  • Fabry disease. Nagueh, S.F. // Heart;Aug2003, Vol. 89 Issue 8, p819 

    Editorial. Evaluates men with Fabry disease, a rare X linked recessive disorder. Cardiac manifestations of Fabry disease; Fabry disease as a cause of hypertrophic cardiomyopathy; Implications of a positive diagnosis of Fabry disease.

  • The Diagnosis and Treatment of Hypertrophic Cardiomyopathy. Prinz, Christian; Farr, Martin; Hering, Detlef; Horstkotte, Dieter; Faber, Lothar // Deutsches Aerzteblatt International;4/1/2011, Vol. 108 Issue 13, following p215 

    A bibliography on the subject of medicine is presented which includes the articles "Hypertrophic cardiomyopathy," "Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment," and "Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy."

  • Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy.  // Journal of Medical Genetics;Sep2007 Supplement 1, Vol. 44, pS79 

    An abstract of the study "Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy" is presented.

  • Hypertrophic Obstructive Cardiomyopathy. Nishimura, Rick A.; Holmes, David R. // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1320 

    Presents a medical case study of hypertrophic obstructive cardiomyopathy. Symptoms of hypertrophic cardiomyopathy including dyspnea, angina and syncope; Therapy for hypertrophic cardiomyopathy directed at the left ventricular outflow tract obstruction; Mortality among patients with hypertrophic...

  • Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment. Louie, Eric K.; Maron, Barry J.; Louie, E K; Maron, B J // Annals of Internal Medicine;May87, Vol. 106 Issue 5, p663 

    Of 965 patients with hypertrophic cardiomyopathy evaluated by echocardiography at the National Institutes of Health during a 7-year period, 23 (2%) had a nonobstructive morphologic form, in which wall thickening occurred predominantly in the apical (distal) portion of the left ventricle. The...

  • Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair. Schwartz, Ketty; Mercadier, Jean-Jacques // Journal of Clinical Investigation;Sep2003, Vol. 112 Issue 5, p652 

    Focuses on the role of cardiac troponin T to the development of familial hypertrophic cardiomyopathy. Hallmarks of familial hypertrophic cardiomyopathy; Functional and energetic consequences of the R92Q mutation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics